Camlin Fine Sciences Ltd
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
- Market Cap ₹ 1,857 Cr.
- Current Price ₹ 111
- High / Low ₹ 186 / 88.4
- Stock P/E 3,869
- Book Value ₹ 46.1
- Dividend Yield 0.00 %
- ROCE 11.0 %
- ROE 7.73 %
- Face Value ₹ 1.00
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 5.40% over last 3 years.
- Company has high debtors of 243 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
252 | 314 | 374 | 431 | 412 | 325 | 403 | 548 | 580 | 600 | 686 | 789 | 771 | |
216 | 268 | 315 | 370 | 344 | 300 | 395 | 515 | 517 | 534 | 605 | 658 | 684 | |
Operating Profit | 36 | 46 | 60 | 61 | 68 | 24 | 8 | 33 | 63 | 66 | 80 | 131 | 87 |
OPM % | 14% | 15% | 16% | 14% | 16% | 8% | 2% | 6% | 11% | 11% | 12% | 17% | 11% |
4 | 3 | 1 | 2 | -1 | 13 | 9 | 14 | 21 | 5 | 19 | 29 | 15 | |
Interest | 16 | 18 | 22 | 21 | 22 | 26 | 26 | 23 | 31 | 36 | 36 | 60 | 54 |
Depreciation | 6 | 9 | 9 | 10 | 10 | 12 | 9 | 9 | 11 | 19 | 27 | 33 | 47 |
Profit before tax | 16 | 23 | 29 | 32 | 35 | 0 | -18 | 14 | 41 | 15 | 36 | 67 | 0 |
Tax % | 38% | 34% | 35% | 19% | 26% | 809% | 22% | 24% | 26% | 45% | 28% | 29% | |
10 | 15 | 19 | 26 | 26 | -1 | -14 | 11 | 31 | 8 | 26 | 48 | 0 | |
EPS in Rs | 1.08 | 1.57 | 2.01 | 2.69 | 2.66 | -0.08 | -1.17 | 0.88 | 2.53 | 0.65 | 1.65 | 3.03 | 0.06 |
Dividend Payout % | 23% | 19% | 17% | 17% | 17% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 10% |
5 Years: | 14% |
3 Years: | 11% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 40% |
3 Years: | 13% |
TTM: | -99% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 19% |
3 Years: | -7% |
1 Year: | -36% |
Return on Equity | |
---|---|
10 Years: | 6% |
5 Years: | 6% |
3 Years: | 5% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9 | 9 | 9 | 10 | 10 | 10 | 12 | 12 | 12 | 13 | 16 | 16 | 17 |
Reserves | 40 | 52 | 67 | 88 | 111 | 165 | 319 | 314 | 365 | 406 | 577 | 626 | 755 |
87 | 107 | 132 | 135 | 159 | 242 | 218 | 313 | 340 | 378 | 461 | 617 | 500 | |
75 | 92 | 79 | 113 | 102 | 56 | 128 | 141 | 175 | 270 | 293 | 335 | 318 | |
Total Liabilities | 211 | 260 | 287 | 346 | 382 | 474 | 678 | 781 | 891 | 1,067 | 1,346 | 1,594 | 1,590 |
48 | 54 | 48 | 63 | 89 | 79 | 72 | 82 | 96 | 294 | 304 | 583 | 582 | |
CWIP | 2 | 1 | 2 | 0 | 1 | 14 | 20 | 68 | 198 | 18 | 207 | 28 | 35 |
Investments | 1 | 1 | 4 | 5 | 7 | 44 | 148 | 69 | 74 | 74 | 82 | 82 | 82 |
159 | 204 | 234 | 278 | 285 | 337 | 438 | 562 | 523 | 681 | 753 | 901 | 891 | |
Total Assets | 211 | 260 | 287 | 346 | 382 | 474 | 678 | 781 | 891 | 1,067 | 1,346 | 1,594 | 1,590 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
8 | 13 | 13 | 26 | 51 | -30 | -5 | -45 | 74 | 26 | 47 | 19 | |
-10 | -10 | -7 | -23 | -49 | -31 | -116 | -3 | -66 | -88 | -172 | -115 | |
1 | 1 | -3 | -5 | -1 | 61 | 120 | 65 | -26 | 80 | 129 | 78 | |
Net Cash Flow | -2 | 3 | 3 | -1 | 0 | 0 | -1 | 17 | -18 | 18 | 3 | -18 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 91 | 80 | 89 | 105 | 87 | 148 | 192 | 174 | 204 | 224 | 235 | 243 |
Inventory Days | 107 | 162 | 75 | 118 | 176 | 209 | 138 | 98 | 91 | 127 | 132 | 252 |
Days Payable | 127 | 136 | 93 | 123 | 119 | 65 | 137 | 95 | 125 | 186 | 196 | 248 |
Cash Conversion Cycle | 72 | 105 | 72 | 100 | 144 | 291 | 192 | 177 | 170 | 165 | 171 | 246 |
Working Capital Days | 110 | 111 | 123 | 118 | 132 | 260 | 245 | 210 | 206 | 220 | 205 | 255 |
ROCE % | 25% | 26% | 28% | 24% | 24% | 7% | 2% | 6% | 11% | 7% | 8% | 11% |
Documents
Announcements
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Dec 2019TranscriptNotesPPT
-
Dec 2019TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
May 2016TranscriptNotesPPT
Business Verticals